In Low- and Middle-Income Countries (LMICs), over 80% of healthcare facilities still lack reliable access to medical oxygen. The COVID-19 pandemic exposed this urgent gap—more than 500,000 LMIC patients require oxygen daily. Rural regions are the most vulnerable due to poor infrastructure, high transport costs, and limited oxygen production capacity.
O₂ Medi Pty Ltd is a South African healthcare startup preparing to launch a pilot program consisting of nine decentralized medical oxygen plants across the Southern African region, including South Africa, Eswatini, Lesotho, Zambia, Zimbabwe, and Botswana.
Our first pilot project will be implemented between the Limpopo and Rustenburg regions in South Africa, strategically selected for their high healthcare burden and limited access to oxygen.
Each decentralized plant will:
We are seeking aligned partners to support the launch and scale of this high-impact initiative. Your sponsorship will enable:
This is an opportunity to co-create sustainable healthcare solutions and strengthen health systems across Southern Africa from the ground up.
O₂ Medi is a mission-driven healthcare innovation company based in South Africa, founded to address systemic gaps in oxygen access through localized production, renewable energy integration, and digital health technologies. Backed by an experienced leadership team and global partners in engineering, energy, and AI, we are ready to deliver transformative impact in LMIC healthcare.
Whether you're interested in partnering with us, supporting our pilot project, or learning more about our work, we’d love to hear from you. Use the form below or reach out directly.
Stay updated on our news and events! Sign up to receive our newsletter.